Fresenius Medical Care Files 2024 Annual Report with SEC

Tip Ranks
2025.02.25 16:48
portai
I'm PortAI, I can summarize articles.

Fresenius Medical Care (FMS) has filed its 2024 annual report on Form 20-F with the SEC, providing audited financial statements and insights into its operational performance. This filing enhances transparency and regulatory compliance for stakeholders. The company, a leader in renal disease products and services, operates 3,675 dialysis clinics globally, serving 4.2 million patients. FMS is publicly traded on the Frankfurt and New York Stock Exchanges, with a current market cap of $13.7B and a year-to-date price performance of 5.24%.

Fresenius Medical Care ( (FMS) ) has shared an update.

On February 25, 2025, Fresenius Medical Care announced the filing of its annual report for the fiscal year 2024 on Form 20-F with the U.S. Securities and Exchange Commission. This report, which includes the complete audited consolidated financial statements, is accessible on both the company’s and the SEC’s websites. This filing is a significant step in maintaining transparency and regulatory compliance, offering stakeholders a detailed view of the company’s financial health and operational performance over the past year.

More about Fresenius Medical Care

Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases, serving approximately 4.2 million patients globally who regularly undergo dialysis treatment. The company operates a network of 3,675 dialysis clinics, providing treatments for around 299,000 patients worldwide, and is a leading supplier of dialysis products such as machines and dialyzers. Fresenius Medical Care is publicly traded on the Frankfurt Stock Exchange and the New York Stock Exchange.

YTD Price Performance: 5.24%

Average Trading Volume: 253,501

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $13.7B

See more insights into FMS stock on TipRanks’ Stock Analysis page.

Trending Articles:

  • Apple’s U.S. Investment Is a Canny Move, Says Daniel Ives
  • SoundHound AI: Impressive Tech but Pricey Stock, Says Cantor
  • Tesla Stock: Upcoming Catalysts Trump Negative Sentiment, Says Wedbush
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.